Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EDC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CLK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYP1A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYP1A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARID3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CSK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LMAN1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CPLX3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ULK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBL7-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
UBL7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEMA7A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYP11A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC33 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on